- Record: found
- Abstract: found
- Article: not found
CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.
Marta Jarque
1 ,
Edoardo Melilli
2 ,
Elena Crespo
1 ,
Anna Manonelles
2 ,
Nuria Montero
2 ,
Joan Torras
1
,
2 ,
Josep M Cruzado
1
,
2 ,
Sergi Luque
1 ,
Salvador Gil-Vernet
2 ,
Josep M Grinyó
1
,
2 ,
Oriol Bestard
1
,
2
Nov 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Whether cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) at prophylaxis cessation predicts D+/R+ kidney transplants at risk of late-onset CMV infection after receiving distinct induction therapies is still not well characterized.